Surgical Treatment of Stage T3 Squamous Cell Carcinomas of the Scalp

Bone Marrow Protective Effect of Trilaciclib in Postoperative CCRT for LA-HNSCC

NCT06752798 ·Status: RECRUITING ·Phase: PHASE2

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

NCT02734537 ·Status: RECRUITING ·Phase: PHASE2

Patient Perspectives in Squamous Cell Carcinoma Clinical Trials

NCT05929547 ·Status: NOT_YET_RECRUITING

Docetaxel in Squamous Cell Carcinoma of the Head and Neck (TAX + Cisplatin in SCCHN)

NCT00268671 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

S0225 Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck Cancer

NCT00095641 ·Status: WITHDRAWN ·Phase: PHASE2

Neoadjuvant Docetaxel Plus Cisplatin and 5-fluorouracil (TPF) Followed by Concomitant Chemoradiotherapy and Chemoradiotherapy Alone in Locally Advanced Squamous Cell Carcinoma of the Head and Neck Patients (SCCHNS)

NCT00357149 ·Status: COMPLETED ·Phase: PHASE2

Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma

NCT03174275 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Temsirolimus + Weekly Paclitaxel + Carboplatin for Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC)

NCT01016769 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Prospective Randomized Trial of Capecitabine Treatment in Patients With HNSCC

NCT03678649 ·Status: UNKNOWN ·Phase: PHASE2

STAT3 DECOY in Head and Neck Cancer

NCT00696176 ·Status: COMPLETED ·Phase: EARLY_PHASE1

A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)

NCT06496178 ·Status: RECRUITING ·Phase: PHASE3

Circulating Tumor Cells as an Early Predictive head-and -Neck Squamous-cell Carcinoma

NCT02119559 ·Status: UNKNOWN ·Phase: NA

New Strategies Against Cutaneous Squamous Cell Carcinoma

NCT02672254 ·Status: COMPLETED

Experience of Non-Melanoma Skin Cancer (NMSC) Mohs Surgery Project

NCT01452984 ·Status: COMPLETED

Study of the Contribution of Mutant p53/YAP Proteins to Therapy Resistance in Recurrent Head and Neck Cancer

NCT06791941 ·Status: RECRUITING

De-escalation of Adjuvant Radio (Chemo) Therapy for HPV-positive Head-neck Squamous Cell Carcinomas

NCT03396718 ·Status: RECRUITING ·Phase: NA

Potentiation of Cetuximab by Tregs Depletion With CSA in Advanced Head & Neck Cancer

NCT01581970 ·Status: COMPLETED ·Phase: PHASE2

Induction Modified TPF Followed by Concurrent Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

NCT05527782 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients

NCT04858269 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

NCT05287113 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Reconstructive Surgery For Head And Neck Cancer Patients

NCT00578032 ·Status: COMPLETED

Pilot Study of Imatinib Cetuximab Combo for H & N Cancer

NCT05816785 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1

Effect of Accelerated RTH in Squamous Cell Carcinoma in Head and Neck

NCT05291663 ·Status: UNKNOWN

The Addition of Pembrolizumab to Postoperative Radiotherapy in Cutaneous Squamous Cell Cancer of the Head and Neck

NCT03057613 ·Status: COMPLETED ·Phase: PHASE2

Proximal Molecular Effects of Concurrent Chemoradiotherapy on Head and Neck Squamous Cell Carcinoma

NCT00620139 ·Status: COMPLETED